The Cooper Companies, Inc. (COO)

The Cooper Companies develops and sells contact lenses through CooperVision and women’s health and fertility products through CooperSurgical. CooperVision is a major global player in soft contact lenses, including daily disposables and specialty designs for astigmatism and myopia management. CooperSurgical supplies clinics and hospitals with devices and consumables for reproductive health and assisted reproduction. The group serves eye-care professionals, patients, and women’s healthcare providers worldwide.

Market
Nasdaq
Also in
S&P 500
Sector
Healthcare
Trend
Downtrend
Last close
69.59 (-1.49% on the day)
MA50
72.64
MA200
73.38
52-week range
58.98–84.32
Market cap
13.7B USD
P/E
59.4
Dividend yield
0%
Data as of
2026-09-04
Quarterly revenue and earnings, millions of USD
QuarterRevenueYoY %EarningsYoY %
Q2 20251,002.387.7
Q3 20251,060.398.3
Q4 20251,065.184.6
Q1 20261,024.1130.8
Q2 20261,081.57.9%-77.9-188.8%

All markets — KeepWinning global stock screener

Other companies on Nasdaq: lululemon athletica inc. (LULU), Five Below, Inc. (FIVE), Exelixis, Inc. (EXEL), Erie Indemnity Company (ERIE), SEI Investments Company (SEIC), Hasbro, Inc. (HAS)